Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Ontology highlight
ABSTRACT: Alzheimer's disease is biologically heterogeneous, and detailed understanding of the processes involved in patients is critical for development of treatments. CSF contains hundreds of proteins, with concentrations reflecting ongoing (patho)physiological processes. This provides the opportunity to study many biological processes at the same time in patients. We studied whether Alzheimer's disease biological subtypes can be detected in CSF proteomics using the dual clustering technique non-negative matrix factorization. In two independent cohorts (EMIF-AD MBD and ADNI) we found that 705 (77% of 911 tested) proteins differed between Alzheimer's disease (defined as having abnormal amyloid, n = 425) and controls (defined as having normal CSF amyloid and tau and normal cognition, n = 127). Using
SUBMITTER: Tijms BM
PROVIDER: S-EPMC7805814 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA